TrialAmyotrophic lateral sclerosis & frontotemporal degeneration2021

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of

Jeremy M Shefner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.